Mutated Gene Appears in One of Three Kidney Cancer Patients
Scientists have pinpointed a gene (PBRM1) that is mutated in approximately one out of three patients with clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer.
Skip the Sun, Eat Your Veggies
Eating a diet rich in fruit and vegetables can give your skin a healthier glow than the sun, according to a study from The University of Nottingham.
Clinical Trial for Sutent Stopped
A phase-3 clinical trial studying the effects of Sutent (sunitinib) has been halted early as the drug is shown to be effective in treating advanced pancreatic islet cell tumors.
A Closer Look at a Killer
New research from Johns Hopkins University suggests why some people with a rare pancreatic cancer are able to live for a decade or longer from diagnosis.
Food for Thought
A new study suggests efforts to determine the nutritional effect on Alzheimer's disease could be improved by using nutrient “biomarkers” in elderly people at risk for dementia.
Mammograms may be able to serve another purpose besides detecting breast cancer. The diagnostic tool has been shown to detect calcifications in the blood vessels of patients with advanced kidney disease.
A Crystal Ball for Colon Cancer?
A genetic test may be able to identify those with stage II colon cancer who face a higher risk of recurrence, according to new research from Germany.
One in a Billion
Clinical trials under way at four cancer-treatment centers in the U.S. may revolutionize the way the second-leading cause of death in the U.S. is treated.
The American Diabetes Association (ADA) has awarded $600,000 to the Albert Einstein College of Medicine of Yeshiva University to study the effects of resveratrol on prediabetes.
New Treatment for MS Approved in U.S., Europe
Pharmaceutical company Novartis AG's multiple sclerosis (MS) drug, Gilenya, has been approved for use in the United States and now Europe to treat relapsing-remitting forms of the disease.